These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 23272152)
1. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. Misra UK; Pizzo SV PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex. Misra UK; Pizzo SV J Cell Biochem; 2012 May; 113(5):1488-500. PubMed ID: 22173835 [TBL] [Abstract][Full Text] [Related]
3. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells. Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235 [TBL] [Abstract][Full Text] [Related]
4. Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation. Kazyken D; Lentz SI; Wadley M; Fingar DC J Biol Chem; 2023 Sep; 299(9):105097. PubMed ID: 37507012 [TBL] [Abstract][Full Text] [Related]
5. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906 [TBL] [Abstract][Full Text] [Related]
6. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells. Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a pro-proliferative feedback loop in prostate cancer: the role of Epac1 and COX-2-dependent pathways. Misra UK; Pizzo SV PLoS One; 2013; 8(4):e63150. PubMed ID: 23646189 [TBL] [Abstract][Full Text] [Related]
9. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. Dormond O; Contreras AG; Meijer E; Datta D; Flynn E; Pal S; Briscoe DM J Immunol; 2008 Dec; 181(11):8088-95. PubMed ID: 19018001 [TBL] [Abstract][Full Text] [Related]
10. mTORC2 is required for proliferation and survival of TSC2-null cells. Goncharova EA; Goncharov DA; Li H; Pimtong W; Lu S; Khavin I; Krymskaya VP Mol Cell Biol; 2011 Jun; 31(12):2484-98. PubMed ID: 21482669 [TBL] [Abstract][Full Text] [Related]
11. Activated α2-macroglobulin binding to cell surface GRP78 induces T-loop phosphorylation of Akt1 by PDK1 in association with Raptor. Misra UK; Pizzo SV PLoS One; 2014; 9(2):e88373. PubMed ID: 24516643 [TBL] [Abstract][Full Text] [Related]
12. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction. Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905 [TBL] [Abstract][Full Text] [Related]
13. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα). Dan HC; Ebbs A; Pasparakis M; Van Dyke T; Basseres DS; Baldwin AS J Biol Chem; 2014 Sep; 289(36):25227-40. PubMed ID: 24990947 [TBL] [Abstract][Full Text] [Related]
14. Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Breuleux M; Klopfenstein M; Stephan C; Doughty CA; Barys L; Maira SM; Kwiatkowski D; Lane HA Mol Cancer Ther; 2009 Apr; 8(4):742-53. PubMed ID: 19372546 [TBL] [Abstract][Full Text] [Related]
15. Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. Foster KG; Acosta-Jaquez HA; Romeo Y; Ekim B; Soliman GA; Carriere A; Roux PP; Ballif BA; Fingar DC J Biol Chem; 2010 Jan; 285(1):80-94. PubMed ID: 19864431 [TBL] [Abstract][Full Text] [Related]
16. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival. Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922 [TBL] [Abstract][Full Text] [Related]
17. Identification of rictor as a novel substrate of Polo-like kinase 1. Shao T; Liu X Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006 [TBL] [Abstract][Full Text] [Related]
18. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421 [TBL] [Abstract][Full Text] [Related]
19. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. Oshiro N; Takahashi R; Yoshino K; Tanimura K; Nakashima A; Eguchi S; Miyamoto T; Hara K; Takehana K; Avruch J; Kikkawa U; Yonezawa K J Biol Chem; 2007 Jul; 282(28):20329-39. PubMed ID: 17517883 [TBL] [Abstract][Full Text] [Related]
20. Intestinal cell kinase (ICK) promotes activation of mTOR complex 1 (mTORC1) through phosphorylation of Raptor Thr-908. Wu D; Chapman JR; Wang L; Harris TE; Shabanowitz J; Hunt DF; Fu Z J Biol Chem; 2012 Apr; 287(15):12510-9. PubMed ID: 22356909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]